TherapeuticsMD TXMD 深 沪
等待开盘 07-14 09:30:00 美东时间
1.97
-0.030
-1.50%
华盛通- 最 高2.00
- 今 开2.00
- 成交量 6985股
- 最 低 1.97
- 昨 收 2.00
- 总市值 2280.15万
- 52周最高 2.95
- 市盈率 静 --
- 换手率 0.06%
- 52周最低 0.99
- 委 比 -55.56%
- 总股本 1157.44万
- 历史最高 563.00
- 量 比 0.18
- 振 幅 1.50%
- 历史最低 0.70
- 每 手 1
- 风险率 0.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TherapeuticsMD Says Company Continues To Evaluate Strategic Alternatives, Including Acquisition Or Merger
The Company continues to evaluate a variety of strategic alternatives that may include, but are not limited to, an acquisition, merger, other business combination, sale of assets, or other strategic transactions
05-13 05:47
TherapeuticsMD Q1 EPS $0.01 Up From $(0.06) YoY, Sales $724.000K Up From $393.000K YoY
TherapeuticsMD (NASDAQ:TXMD) reported quarterly earnings of $0.01 per share. This is a 116.67 percent increase over losses of $(0.06) per share from the same period last year. The company reported $724.000 thousand in
05-13 05:19
TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives
TherapeuticsMD ( ($TXMD) ) has provided an update. TherapeuticsMD, Inc. reporte...
05-13 04:47
TherapeuticsMD Explains Brief Delay In Annual Filing
TherapeuticsMD ( ($TXMD) ) has released a notification of late filing. Therapeu...
04-01 23:39
TherapeuticsMD delays 2025 10-K after filing omits auditor report
TherapeuticsMD delays 2025 10-K after filing omits auditor report TherapeuticsMD filed a Form 12b-25, flagging a delay in its fiscal 2025 Form 10-K. Annual report filed March 30, 2026 omitted audit report for fiscal 2024 financial statements due to a printer error. Company refiled Form 10-K on April
04-01 18:08
TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy
The latest announcement is out from TherapeuticsMD ( ($TXMD) ). On March 30, 20...
03-31 08:12
TherapeuticsMD Q4 EPS $(0.06) Down From $0.01 YoY, Sales $893.000K Up From $667.000K YoY
TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.06) per share. This is a 700 percent decrease over earnings of $0.01 per share from the same period last year. The company reported $893.000 thousand in
03-31 06:10
TherapeuticsMD Q3 Sales $784.000K Up From $547.000K YoY
TherapeuticsMD (NASDAQ:TXMD) reported $784.000 thousand in sales this quarter. This is a 43.33 percent increase over sales of $547.000 thousand the same period last year.
2025-11-13 05:31
TherapeuticsMD Q2 EPS $0.05 Up From $(0.09) YoY, Sales $1.000M Up From $234.000K YoY
TherapeuticsMD (NASDAQ:TXMD) reported quarterly earnings of $0.05 per share. This is a 155.56 percent increase over losses of $(0.09) per share from the same period last year. The company reported $1.000 million in
2025-08-13 04:29
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Lyra Therapeutics (NASDAQ:LYRA) stock rose 376.8% to $23.5 during Mond...
2025-06-03 01:06
